Nov 6 (Reuters) - British medical products maker Smith & Nephew (SN.L), opens new tab on Thursday missed market expectations for quarterly revenue due to weakness in its U.S. knee implants business, ...
Smith & Nephew's third-quarter performance included year-over-year revenue growth in the orthopedics and sports medicine segments of 4% and 5%, respectively, on an underlying basis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback